ImageneBio, Inc. — Director's Dealing 2024

Jun 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ikena Oncology, Inc. (IKNA)
CIK: 0001835579
Period of Report: 2024-06-07

Reporting Person: Wooster Richard (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-07	Stock Option (Right to Buy)	$1.75	A	17520	Acquired	2034-06-06	Common Stock (17520)	Direct

Footnotes

F1: This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.